CELL HERBS, LLC – Trademark Portfolio

Entity Type: 16

CELL HERBS, LLC holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 2 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include CELL HERBS and R-E-D REVERSING ERECTILE DYSFUNCTION. The owner is based in DELRAY BEACH, FL.

Suite #E-5

DELRAY BEACH, FL 33484

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

CELL HERBS, LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (2 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

35
Advertising & Business (1 filing)

Advertising; business management; business administration; office functions

Frequently Asked Questions

How many trademarks does CELL HERBS, LLC have?

CELL HERBS, LLC has 3 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 abandoned.

What trademark classes does CELL HERBS, LLC file in?

CELL HERBS, LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 35 (Advertising & Business). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are CELL HERBS, LLC's most well-known trademarks?

CELL HERBS, LLC's registered trademark portfolio includes well-known marks such as CELL HERBS and R-E-D REVERSING ERECTILE DYSFUNCTION. These are among 2 currently registered trademarks in the portfolio.

What is CELL HERBS, LLC's trademark registration success rate?

CELL HERBS, LLC has a 67% trademark registration rate, with 2 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.